(58) reported a predictive value of high baseline SAA levels (measured at diagnosis) for an early relapse in patients with GCA receiving corticosteroids, indicating a clinical utility of SAA in an early identification of non-responders to corticosteroid therapy. Here, SAA2 is linked to temporal arteritis.